| # | Drug | Count |
|---|---|---|
| 0 | NALTREXONE | 35 |
| 1 | GABAPENTIN | 13 |
| 2 | PALIPERIDONE PALMITATE | 13 |
| 3 | OCTREOTIDE ACETATE | 12 |
| 4 | INTERFERON BETA-1A | 11 |
| 5 | OMEPRAZOLE MAGNESIUM | 11 |
| 6 | MORPHINE | 10 |
| 7 | BUPRENORPHINE | 9 |
| 8 | ETANERCEPT | 8 |
| 9 | LEUPROLIDE ACETATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| 1 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 2 | NALTREXONE | 35 | 0.0011 |
| 3 | ARIPIPRAZOLE LAUROXIL | 4 | 0.0009 |
| 4 | DEOXYCHOLIC ACID | 2 | 0.0009 |
| 5 | SENNA LAXATIVE | 1 | 0.0008 |
| 6 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 7 | CABOTEGRAVIR AND RILPIVIRINE | 4 | 0.0006 |
| 8 | TESAMORELIN | 1 | 0.0006 |
| 9 | ESTRIOL | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 1 | GLP-1 Receptor Agonist [EPC] | 17 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 12 |
| 3 | Interferon beta [EPC] | 12 |
| 4 | Neuromuscular Blocker [EPC] | 12 |
| 5 | Corticosteroid [EPC] | 11 |
| 6 | Opioid Agonist [EPC] | 10 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 8 | Benzodiazepine [EPC] | 9 |
| 9 | Insulin Analog [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Cytolytic Agent [EPC] | 2 | 0.0009 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 9 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |